期刊文献+

婴儿期发病的腓骨肌萎缩症家系PMP22基因突变研究

PMP22 mutation of an infant-onset Charcot-Marie-Tooth disease family
原文传递
导出
摘要 目的研究一个婴儿期发病的腓骨肌萎缩症(CMT)家系PMP22基因突变,探讨该家系CMT的遗传学特点。方法应用STR结合多重PCR法对2例CMT患儿及该家系内15名表型正常的成员进行PMP22基因重复突变的分析。同时选择20名健康人做为对照。结果在2名CMT患儿及5名家系内表型正常的成员中发现了PMP22基因重复突变,其中5例突变在STR位点D17S921,2例突变在STR位点D17S4A,而家系内其余10名成员及20名健康人未发现突变。结论该CMT家系的致病基因为17p11.2-p12区域内包含PMP22基因的重复突变,其亚型为CMT1A。 Objective To study the mutation of PMP22 gene of an early-onset family with Charcot-Marie-Tooth disease(CMT) and the genetic features of the disease.Methods Two patients with CMT,fifteen unaffected members in the family and 20 healthy controls were enrolled.STR-PCR and gene scanning were used to detect PMP22 duplication mutation.Results The mutations of PMP22 were found in the two patients and other five unaffected members in the family.The mutations were located in the STR locus D17S921 in 5 cases and in the STR locus D17S4A in 2 cases.The other members in the family and 20 healthy controls did not show the mutations of PMP22.Conclusions The gene causing CMT in the family is found in the 17p11.2-p12 region containing PMP22 gene duplication mutation,resulting in the subtype CMT1A.
出处 《中国当代儿科杂志》 CAS CSCD 北大核心 2011年第10期799-803,共5页 Chinese Journal of Contemporary Pediatrics
基金 国家自然科学基金资助项目(No.30571597)
关键词 腓骨肌萎缩症 遗传 PMP22 突变 婴儿 Charcot-Marie-Tooth disease Genetics PMP22 Mutation Infant
  • 相关文献

参考文献14

  • 1Howcroft DWJ, Umar SK, Makwana N. Charcot Marie Tooth disease[J]. Orthop Trauma, 2009,23 (4) : 274-277.
  • 2Choi BO, Lee MS, Shin SH, Hwang JH, Choi KG, Kim WK, et al. Mutational analysis of PMP22, MPZ, GJB1, EGR2 and NEFL in Korean Charcot-Marie-Tooth neuropathy patients [ J ]. Human Mutat, 2004, 24(2):185-186.
  • 3Padua L, Shy ME, Aprile I, Cavallaro T, Pareyson D, Quattrone A, et al. Correlation between chnical/neurophysiological findings and quality of life in Charcot-Marie-Tooth type 1A[J]. J Peripher Nerv Syst, 2008, 13 (1) :64-70.
  • 4Padua L, Aprile I, Cavallaro T, Commodari I, La Torre G, Pareyson D, et al. Variables influencing quality of life and disability in Chareot Marie Tooth (CMT) patients: Italian multieentre study [J]. Neurol Sci, 2006, 27(6) :417-423.
  • 5Pareyson D. Differential diagnosis of Charcot-Marie-Tooth disease and related neuropathies[ J]. Neurol Sci, 2004, 25 (2) :72-82.
  • 6Szigeti K, Nelis E, Lupski JR. Molecular diagnostics of Charcot- Marie-Tooth disease and related peripheral neuropathies [ J ]. Neuromolecular Med, 2006, 8(1-2) :243-254.
  • 7Carter GT, England JD, Chance PF. Charcot-Marie-Tooth disease: electrophysiology, molecular genetics and clinical management[J]. IDrugs, 2004, 7(2) :151-159.
  • 8Corrado G, Cheecarelli N, Santarone M, Stollberger C, Finsterer J. Left ventricular hypertrabeculation/noncompation with PMP22 duplication-based Charcot-Marie-Tooth type 1A[J]. Cardiology, 2006, 105(3) :142-145.
  • 9Passage E, Norreel JC, Noack-Fraissignes P, Sanguedolce V, Pizant J, Thirion X, et al. Ascorbic acid treatment corrects the phenotype of a mouse model of Charcot-Marie-Tooth disease[J]. Nat Med, 2004, 10(4) :396-401.
  • 10Kaya F, Belin S, Bourgeois P, Micaleff J, Blin O, Fontes M. Ascorbic acid inhibits PMP22 expression by reducing cAMP levels [ J ]. Neuromuscul Disord, 2007, 17 (3) :248-253.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部